MARCHF11 and non-small cell lung carcinoma: Vrba et al. [115] clinically evaluated a set of ten DNA methylation biomarkers (LINC01158, CCDC181, PRKCB, TBR1, ZNF781, MARCH11, VWC2, SLC9A3, HOXA7) in NSCLC patients, showing significant differences in the methylation pattern of these biomarkers between NSCLC patients and healthy subjects.